Table 2 The relationship between the NLRP3 mRNA expression and patient’s clinicopathological parameters in gastric cancer.
Clinicopathological parameters | Number | NLRP3 mRNAhigh expression group (n = 64) | NLRP3 mRNAlow expression group (n = 64) | Χ2 | P | |
|---|---|---|---|---|---|---|
Age | < 60 | 29 | 16 | 13 | 0.33 | 0.526 |
≥ 60 | 99 | 48 | 51 | |||
Gender | Male | 85 | 54 | 31 | 1.16 | 0.214 |
Female | 43 | 10 | 33 | |||
Tumor size | < 5 cm | 76 | 27 | 49 | 5.64 | 0.043* |
≥ 5 cm | 52 | 37 | 15 | |||
Lymph node metastasis | no | 39 | 19 | 20 | 8.75 | 0.002* |
yes | 89 | 45 | 44 | |||
TNM staging | I + II | 35 | 9 | 26 | 11.24 | 0.001* |
III + IV | 93 | 55 | 38 | |||
Differentiation | High | 41 | 11 | 30 | 9.70 | 0.003* |
Moderate or poor | 87 | 53 | 34 | |||
Position | Antrum | 65 | 34 | 31 | 0.36 | 0.577 |
Other | 63 | 30 | 33 | |||